tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ABCL Stock Latest News

AbCellera doses first patients in Phase 2 portion of ABCL635 trial
The FlyAbCellera doses first patients in Phase 2 portion of ABCL635 trial
2d ago
ABCL
Viking Therapeutics names Neil Aubuchon as Chief Commercial Officer
PremiumThe Fly
Viking Therapeutics names Neil Aubuchon as Chief Commercial Officer
7d ago
ABCL
VKTX
AbCellera Secures Global Settlement and Patent License Deal
PremiumCompany Announcements
AbCellera Secures Global Settlement and Patent License Deal
26d ago
8K
ABCL
AbCellera to receive $36M upfront in patent litigation settlement with Bruker
PremiumThe Fly
AbCellera to receive $36M upfront in patent litigation settlement with Bruker
27d ago
ABCL
BRKR
Strategic Shift and Promising Antibody Therapeutics Drive Buy Rating for AbCellera Biologics
PremiumRatings
Strategic Shift and Promising Antibody Therapeutics Drive Buy Rating for AbCellera Biologics
2M ago
ABCL
AbCellera Appoints Dr. Stephen Quake to Board
PremiumCompany AnnouncementsAbCellera Appoints Dr. Stephen Quake to Board
2M ago
8K
ABCL
AbCellera Biologics’ Earnings Call: Key Insights
Premium
Company Announcements
AbCellera Biologics’ Earnings Call: Key Insights
2M ago
ABCL
3 Best Stocks to Buy Now, 11/7/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 11/7/2025, According to Top Analysts
2M ago
ABCL
BLND
AbCellera downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
AbCellera downgraded to Market Perform from Outperform at Leerink
2M ago
ABCL
AbCellera Biologics Reports Q3 2025 Financial Results
PremiumCompany Announcements
AbCellera Biologics Reports Q3 2025 Financial Results
2M ago
ABCL
AbCellera Biologics Reports Q3 2025 Financial Results
PremiumCompany Announcements
AbCellera Biologics Reports Q3 2025 Financial Results
2M ago
8K
ABCL
AbCellera reports Q3 EPS (19c), consensus (16c)
PremiumThe Fly
AbCellera reports Q3 EPS (19c), consensus (16c)
2M ago
ABCL
AbCellera’s ABCL635 Study: A Promising Step for Menopause Treatment
PremiumCompany AnnouncementsAbCellera’s ABCL635 Study: A Promising Step for Menopause Treatment
3M ago
ABCL
AbCellera’s Phase 1 Study of ABCL575: A Potential Game-Changer?
Premium
Company Announcements
AbCellera’s Phase 1 Study of ABCL575: A Potential Game-Changer?
3M ago
ABCL
AbCellera Biologics Appoints New Chief Medical Officer
Premium
Company Announcements
AbCellera Biologics Appoints New Chief Medical Officer
4M ago
8K
ABCL
AbCellera appoints Sarah Noonberg as Chief Medical Officer
PremiumThe Fly
AbCellera appoints Sarah Noonberg as Chief Medical Officer
4M ago
MGX
ABCL
AbCellera doses first participants in Phase 1 trial of ABCL575
PremiumThe Fly
AbCellera doses first participants in Phase 1 trial of ABCL575
5M ago
ABCL
AbCellera Biologics Earnings Call: Clinical Progress and Financial Insights
PremiumCompany Announcements
AbCellera Biologics Earnings Call: Clinical Progress and Financial Insights
5M ago
ABCL
AbCellera price target raised to $7 from $5 at BMO Capital
PremiumThe Fly
AbCellera price target raised to $7 from $5 at BMO Capital
5M ago
ABCL
AbCellera Biologics Advances Clinical Trials and Revenue Growth
PremiumCompany AnnouncementsAbCellera Biologics Advances Clinical Trials and Revenue Growth
5M ago
ABCL
AbCellera Biologics: Promising Pipeline and Strategic Focus Justify Buy Rating
Premium
Ratings
AbCellera Biologics: Promising Pipeline and Strategic Focus Justify Buy Rating
5M ago
ABCL
AbCellera Biologics Reports Q2 2025 Financial Results
Premium
Company Announcements
AbCellera Biologics Reports Q2 2025 Financial Results
5M ago
8K
ABCL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >